Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

Top Keywords

GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

FACING BIOTECH'S CHALLENGES AND SEIZING OPPORTUNITIES IN 2009

4/30/2009

- Interview with Joshua Boger, Ph.D., Founder and CEO, Vertex Pharmaceuticals, and Chairman, Board of Directors, Biotechnology Industry Organization (BIO), and James Greenwood, President and CEO, BIO

The biotechnology industry, like virtually all other global businesses, is trying to cope with the dismal economic environment. For biotech companies to survive and thrive they must have access to regular sources of funding. Otherwise, R&D efforts and commercialization activities will be severely curtailed or might even come to a halt. But what do they do when money is so tight and formerly reliable investors are now reluctant to provide financial support?

During this week's podcast, James Greenwood reveals what BIO companies are telling him about how the economy is impacting their operations and discusses what all this augurs for new drug development. Vertex Pharmaceuticals' Dr. Josua Boger provides insights on the economy from the perspective of one of the leading biopharmaceutical firms.

Greenwood and Dr. Boger also look at President Obama's 100 days in office and offer their views on the president as a supporter of biotech. They talk about presidential decisions that have impressed them and describe what additional steps they would you like to see him take to revitalize life science research.

Greenwood delineates BIO's legislative priorities for 2009 and Dr. Boger, who is retiring from his CEO position at Vertex in May, offers some words of wisdom regarding what it takes to run and ultimately succeed as a biotech company.

Joshua Boger, Ph.D., Founder and CEO, Vertex Pharmaceuticals, and Chairman, Board of Directors, Biotechnology Industry Organization (BIO)

James Greenwood, President and CEO, BIO

Subscription center

GEN MAGAZINE
	Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization. Subscribe

e-NEWSLETTERS
Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
GEN Daily News Highlights - provides succinct and timely biotech news on the entire biotech field. GEN News Highlights of the Week - showcases the week's top biotech news. GEN Table of Contents (TOC) Alert - This alert provides a sneak peak at the latest issue of GEN. GEN Tech Focus - is published monthly to provide the latest advances in biotech's hottest topics. GEN Biotech Events - a weekly newsletter featuring webinars, meetings, and conferences. GEN New Products Watch - a monthly summary of products and services by tool providers. New product information and special offers from select biotech suppliers.
	All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format


	Sign Up